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ABSTRACT
Hospital antibiotic consumption is generally
adjusted to occupancy. This study hypothesised
that the number of blood culture samples could
be a surrogate marker for case-mix adjustment.
Antibiotic consumption was compared over 16
consecutive trimesters in one medical ward in
terms of patient-days or blood culture samples.
Compared with patient-days, measurement
adjusted to blood culture samples detected three
trimesters with an unusually high consumption,
and one trimester with consumption falsely
classiﬁed as high because of a high incidence of
infections. Blood culture numbers enabled easy
and accurate identiﬁcation of periods with a drift
in antibiotic consumption in a medical ward.
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Surveillance of antibiotic use and feedback of the
data to prescribers has been recommended as a
measure for the containment of bacterial resist-
ance [1–7]. Antibiotic consumption is often report-
ed in terms of deﬁned daily doses (DDD) (http://
www.whocc.no/atcddd/) and then adjusted
according to an indicator of hospital occupancy,
most often patient-days. One limitation of this
measurement scale is its inability to adjust anti-
biotic use according to variation in the case-mix
over time. Antibiotic consumption is driven by
the incidence of bacterial infections and by
the prescribing practices of physicians. The inci-
dence of infection on a ward may be seasonal, or
may vary because of unpredictable political or
epidemiological circumstances. Adjustment for
these variations is therefore vital for proper
identiﬁcation of possible drifts in prescription
practice.
Because blood cultures are often requested in
hospitals when an infection is suspected, this
study examined the hypothesis that the number
of blood samples drawn for culture is a surrogate
marker of the burden of infections in a hospital
ward. The consumption of systemic antibiotics (J01
drugs in the Anatomical Therapeutic Chemical
classiﬁcation) (http://www.whocc.no/atcddd/)
was compared in terms of DDD ⁄patient-day or
DDD ⁄blood sample drawn for culture (referred to
hereafter as blood culture) for accurate detection of
periods with high antibiotic consumption.
The study was performed retrospectively over
16 consecutive trimesters in a 50-bed general
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Fig. 1. Four-year quarterly use of antibiotics in a medical
ward reported in deﬁned daily doses (DDD) per patient-
day (x-axis) or per the number of blood samples drawn for
culture (y-axis). The line at one standard deviation above
the mean on each axis divides the plot into four quadrants:
quadrant A, high use on both scales; quadrant B, high use
only when reported per patient-day; quadrant C, low use
on both scales; quadrant D, high use only when reported
per blood sample for culture. The open circle represents
the reference trimester (see text). The star represents the
mean use on both scales.
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medical ward of a Swiss university hospital.
Delivery data were obtained from the pharmacy
electronic database. The quarterly number of
blood cultures was obtained from the microbio-
logy electronic database. Trimesters were chosen
as time units, because these data were updated
every 3 months.
Fig. 1 shows the quarterly antibiotic consump-
tion data. The Spearman correlation coefﬁcient
was 0.64 (p 0.007) between both measurement
scales. Two trimesters had a rate of consumption
that was more than one standard deviation above
the mean according to the two measurement
scales (quadrant A). Three trimesters were found
that had a high rate of consumption only when
reported per blood culture (quadrant D). To
determine whether this discrepancy was caused
by a difference in the use of antibiotics or in the
use of blood cultures, a computer-generated ran-
dom sample of 50 patients from one of these
trimesters (arbitrarily chosen) was compared with
patients from a reference trimester (identiﬁed
mathematically by minimising the sum of the
relative distance to themean on both scales). These
samples were analysed for any correlation bet-
ween the occurrence of infection (based on the
judgement of the clinician, as reported in the
patients’ medical records) and the taking of blood
cultures. Blood cultures drawn within 48 h of the
onset of an infection were considered to be
related to the infection. The proportion of
infections that motivated blood cultures was
15 ⁄ 24 (63%) in the reference trimester and 12 ⁄ 19
(63%) in the trimester in quadrant D. The pro-
portions of blood cultures performed in the
context of an infection were 15 ⁄ 24 (63%) and
12 ⁄ 16 (75%) in the reference trimester and the
trimester in quadrant D, respectively. The inci-
dence of infection was indeed lower in the
sample from the trimester in quadrant D
(36 ⁄ 1000 patient-days) than in the reference
trimester (46 ⁄ 1000 patient-days). Thus, measure-
ment of antibiotic use per blood culture appeared
to detect three trimesters with an unusually high
use of antibiotics relative to their burden of
infection that would not have been suspected on
a per-patient-day scale.
In contrast, one trimester showed a high anti-
biotic use per patient-day, but not per blood
culture (quadrant B). Detailed analysis of a ran-
dom sample from this trimester revealed a high
incidence of infection (55 ⁄ 1000 patient-days) com-
pared with the reference trimester (46 ⁄ 1000
patient-days). Thus, high antibiotic use in this
case could be attributed to a high incidence of
infection that, appropriately, resulted in a normal
consumption when measured per blood culture. It
therefore seems that measurement of antibiotic
use per blood culture provides additional infor-
mation at no cost, given that the number of blood
cultures taken is information that is available
readily in most hospitals. This information helps
in the identiﬁcation of trends that may motivate a
more detailed investigation in order to audit the
appropriateness of use and evaluate the need for
intervention [8].
This method has several limitations. Stability
over time in the practice of blood cultures is a
prerequisite for their use as surrogate markers of
the case-mix for adjustment of antibiotic con-
sumption. In the present study, the correlation
between the practice of blood cultures and infec-
tions was stable over time in the medical ward
investigated. Implementation of institutional
guidelines for the practice of blood culture could
help to ensure the stability of this correlation.
However, the correlation between infection and
the number of cultures from any body site, or any
normally sterile site, was poorer than with the
number of blood cultures.
It is also uncertain whether the results of this
study, which was limited to one ward in one
hospital, can be generalised to other settings.
The same correlation between blood cultures
and infections was found in another general
medical ward and in an intensive care unit of
the same hospital, but the correlation was poor
in a general surgery ward (data not shown). The
practice of blood cultures may actually vary
among wards with different patient popula-
tions and among hospitals, thus precluding
comparisons.
A consequence of these limitations is the need
to assess how the practice of blood cultures
correlates with the incidence of infections in a
given setting before using blood cultures as a
surrogate marker. Following the proportion of
positive blood cultures over time may be a
simple way to assess this correlation. Neverthe-
less, it seems that the number of blood cul-
tures taken can be used as a marker of the
burden of infection in patients of a medical
ward, provided that a stable policy exists.
Reporting antibiotic use according to the num-
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ber of blood cultures allows accurate identiﬁca-
tion of periods with an unexplained high rate of
antibiotic consumption that deserve further
detailed investigation.
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